Contact Us
A
F
o
c
u
s
e
d
F
o
r
c
e
A
g
a
i
n
s
t
F
e
n
t
a
n
y
l
Leadership
Collin Gage
Collin Gage

Co-Founder, Chief Executive Officer & Director

Stacy McIntosh
Stacy McIntosh

Co-Founder, Chief Operating Officer & Head of Regulatory Affairs

JR Rahn
JR Rahn

Founder

Dr. Ofer Levy
Dr. Ofer Levy

Scientific Co-Founder & Medical Advisor

Dr. Colin Haile
Dr. Colin Haile

Scientific Co-Founder & Advisor

Dr. David Dowling
Dr. David Dowling

Scientific Co-Founder

Olivier Roussy Newton
Olivier Roussy Newton

Founding Investor

Team & Board of Directors
Judy Ashworth, MD
Judy Ashworth, MD

Interim Chief Medical Officer

Michael Jenkins, PhD
Michael Jenkins, PhD

SVP of Manufacturing

Emily Brown
Emily Brown

Corporate Development Associate

Ann Brooke
Ann Brooke

Director of Administration

Ken Kohn
Ken Kohn

Chairman

Collin Gage
Collin Gage

Director

Denise Shull
Denise Shull

Director

Jeffrey Hwang
Jeffrey Hwang

Director

U
n
i
t
i
n
g
t
h
e
N
a
t
i
o
n
’
s
T
o
p
P
r
e
c
i
s
i
o
n
V
a
c
c
i
n
e
S
p
e
c
i
a
l
i
s
t
s
a
s
C
o
-
F
o
u
n
d
e
r
s
a
n
d
S
t
r
a
t
e
g
i
c
P
a
r
t
n
e
r
s
Colin Haile
Colin Haile
Scientific Co-Founder & Advisor

Dr. Colin Haile co-invented the OVAX-100 vaccine and is a leading national expert on fentanyl overdose solutions. He is a former research fellow at Yale University School of Medicine where he focused on addiction disorders.

Ofer Levy, MD, PhD
Ofer Levy, MD, PhD
Scientific Co-Founder & Medical Advisor

Dr. Ofer Levy co-invented OVAX-200 and directs the Precision Vaccines Program at Boston Children’s Hospital. He serves on the U.S. Food & Drug Administration Vaccines and Related Biologic Products Advisory Committee (VRBPAC) and is a Professor of Pediatrics at Harvard Medical School.

David Dowling, PhD
David Dowling, PhD
Scientific Co-Founder

Dr. David Dowling co-invented OVAX-200 and is a leading immunologist and vaccinologist. He is a faculty member in the Precision Vaccine Program at Boston Children's Hospital and an instructor of Pediatrics at Harvard Medical School.

© 2024 OVAX, Inc., All rights reserved. Privacy Policy & Terms of Use